These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 30659894)

  • 1. A novel technique for intraduodenal administration of drug suspensions/solutions with concurrent pH monitoring applied to ibuprofen formulations.
    Hofmann M; Thieringer F; Nguyen MA; Månsson W; Galle PR; Langguth P
    Eur J Pharm Biopharm; 2019 Mar; 136():192-202. PubMed ID: 30659894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical, dissolution stability and microscopic evaluation of suspensions of ibuprofen and sustained release ibuprofen-wax microspheres.
    Adeyeye CM; Price JC
    J Microencapsul; 1997; 14(3):357-77. PubMed ID: 9147285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel approach for determination of correlation between in vivo and in vitro dissolution using the optimization technique.
    Ishii K; Saitou Y; Yamada R; Itai S; Nemoto M
    Chem Pharm Bull (Tokyo); 1996 Aug; 44(8):1550-5. PubMed ID: 8795273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differing disintegration and dissolution rates, pharmacokinetic profiles and gastrointestinal tolerability of over the counter ibuprofen formulations.
    Bjarnason I; Sancak O; Crossley A; Penrose A; Lanas A
    J Pharm Pharmacol; 2018 Feb; 70(2):223-233. PubMed ID: 29238984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation and evaluation of reconstitutable suspensions containing ibuprofen-loaded Eudragit microspheres.
    Devrim B; Bozkir A; Canefe K
    Acta Pol Pharm; 2011; 68(4):593-9. PubMed ID: 21796942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comminution of ibuprofen to produce nano-particles for rapid dissolution.
    Plakkot S; de Matas M; York P; Saunders M; Sulaiman B
    Int J Pharm; 2011 Aug; 415(1-2):307-14. PubMed ID: 21683776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro prediction of in vivo absorption of ibuprofen from suspensions through rational choice of dissolution conditions.
    Hofmann M; García MA; Al-Gousous J; Ruiz-Picazo A; Thieringer F; Nguyen MA; Månsson W; Galle PR; Langguth P
    Eur J Pharm Biopharm; 2020 Apr; 149():229-237. PubMed ID: 32112894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soft, chewable gelatin-based pharmaceutical oral formulations: a technical approach.
    Dille MJ; Hattrem MN; Draget KI
    Pharm Dev Technol; 2018 Jun; 23(5):504-511. PubMed ID: 28532266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale for ibuprofen co-administration with antacids: potential interaction mechanisms affecting drug absorption.
    Parojcić J; Corrigan OI
    Eur J Pharm Biopharm; 2008 Jun; 69(2):640-7. PubMed ID: 18280125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biowaiver monographs for immediate release solid oral dosage forms: ibuprofen.
    Potthast H; Dressman JB; Junginger HE; Midha KK; Oeser H; Shah VP; Vogelpoel H; Barends DM
    J Pharm Sci; 2005 Oct; 94(10):2121-31. PubMed ID: 16136567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Biopredictive In Vitro Comparison of Oral Locally Acting Mesalazine Formulations by a Novel Dissolution Model for Assessing Intraluminal Drug Release in Individual Subjects.
    Karkossa F; Klein S
    J Pharm Sci; 2018 Jun; 107(6):1680-1689. PubMed ID: 29499277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanosizing drug particles in supercritical fluid processing.
    Pathak P; Meziani MJ; Desai T; Sun YP
    J Am Chem Soc; 2004 Sep; 126(35):10842-3. PubMed ID: 15339159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Product development studies on the tablet formulation of ibuprofen to improve bioavailability.
    Ghosh LK; Ghosh NC; Chatterjee M; Gupta BK
    Drug Dev Ind Pharm; 1998 May; 24(5):473-7. PubMed ID: 9876610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-vitro evaluation of sustained release ibuprofen microspheres.
    Ghaly ES; Sepúlveda S
    P R Health Sci J; 1996 Jun; 15(2):97-100. PubMed ID: 8936613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving the tablet characteristics and dissolution profile of ibuprofen by using a novel coprocessed superdisintegrant: a technical note.
    Gohel M; Parikh R; Brahmbhatt B; Shah A
    AAPS PharmSciTech; 2007 Feb; 8(1):13. PubMed ID: 17408213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation and delivery strategies of ibuprofen: challenges and opportunities.
    Irvine J; Afrose A; Islam N
    Drug Dev Ind Pharm; 2018 Feb; 44(2):173-183. PubMed ID: 29022772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors Affecting Successful Extrapolation of Ibuprofen Exposure from Adults to Pediatric Populations After Oral Administration of a Pediatric Aqueous Suspension.
    Statelova M; Holm R; Fotaki N; Reppas C; Vertzoni M
    AAPS J; 2020 Nov; 22(6):146. PubMed ID: 33184711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of population pharmacokinetic models and optimal sampling times for ibuprofen tablet and suspension formulations in children with cystic fibrosis.
    Beringer P; Aminimanizani A; Synold T; Scott C
    Ther Drug Monit; 2002 Apr; 24(2):315-21. PubMed ID: 11897978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of Dissolution Media and Presence of Alcohol on the In Vitro Performance of Pharmaceutical Products Containing an Insoluble Drug.
    Friuli V; Bruni G; Musitelli G; Conte U; Maggi L
    J Pharm Sci; 2018 Jan; 107(1):507-511. PubMed ID: 28624418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of in situ granulation-induced changes in pre-compression, solubility, dose distribution and intrinsic in vitro release characteristics of ibuprofen-cationic dextran conjugate crystanules.
    Abioye AO; Kola-Mustapha A; Chi GT; Ilya S
    Int J Pharm; 2014 Aug; 471(1-2):453-77. PubMed ID: 24886691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.